| scholarly article | Q13442814 |
| P50 | author | Rui Medeiros | Q38327360 |
| P2093 | author name string | Maria Fragoso | |
| Deolinda Pereira | |||
| Cláudia Vieira | |||
| P2860 | cites work | Bisphosphonates for breast cancer | Q24246519 |
| Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration | Q24650864 | ||
| Effectiveness of the World Health Organization cancer pain relief guidelines: an integrative review | Q26741525 | ||
| Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain | Q28074857 | ||
| Metastatic bone disease: clinical features, pathophysiology and treatment strategies | Q28202792 | ||
| Pain assessment: global use of the Brief Pain Inventory | Q28247739 | ||
| Toxicity and response criteria of the Eastern Cooperative Oncology Group | Q29619399 | ||
| Gender Differences in Patients with Fibromyalgia Undergoing Cognitive-Behavioral Therapy for Insomnia: Preliminary Data. | Q31042676 | ||
| Efficacy of ibandronate in metastatic bone disease: review of clinical data | Q33226448 | ||
| Incidence of carnitine deficiency in patients with cancer pain: A pilot study | Q33597627 | ||
| Health-Related Quality of Life of the General German Population in 2015: Results from the EQ-5D-5L | Q33616369 | ||
| Mechanisms of bone metastasis | Q33977526 | ||
| Nonopioid drugs in the treatment of cancer pain. | Q34418992 | ||
| Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphon | Q34656370 | ||
| Bisphosphonates: clinical experience | Q35905962 | ||
| Pain in cancer patients unrelated to the cancer or treatment | Q36075724 | ||
| Latin-American guidelines for cancer pain management | Q36317288 | ||
| The measurement of pain from metastatic bone disease: capturing the patient's experience | Q36633785 | ||
| Oral burning sensation: prevalence and gender differences in a Japanese population. | Q51577492 | ||
| Optimal pain management for patients with cancer in the modern era. | Q52617829 | ||
| Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey. | Q53288431 | ||
| Zoledronic Acid Dosing Interval for Metastatic Cancer-Reply. | Q53363512 | ||
| Cancer pain assessment and management by housestaff | Q71852075 | ||
| [Development of the Portuguese version of MOS SF-36. Part II --Validation tests] | Q73063913 | ||
| Lack of adherence with the analgesic regimen: a significant barrier to effective cancer pain management | Q77316757 | ||
| Evidence-based guidelines for interventional pain medicine according to clinical diagnoses | Q84259127 | ||
| [Cancer pain management: Systematic review and critical appraisal of clinical practice guidelines] | Q86323454 | ||
| Prevalence of pain in patients with cancer: a systematic review of the past 40 years | Q36758835 | ||
| Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel | Q36955961 | ||
| Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations | Q37022616 | ||
| Variable response to opioid treatment: any genetic predictors within sight? | Q37187101 | ||
| Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial | Q37660462 | ||
| Pharmacological treatment of chronic pain - the need for CHANGE. | Q37718813 | ||
| Diagnosing neuropathic pain in patients with cancer: comparative analysis of recommendations in national guidelines from European countries. | Q38070867 | ||
| Survival of women with cancers of breast and genital organs in Europe 1999-2007: Results of the EUROCARE-5 study | Q38384241 | ||
| Skeletal metastases from breast cancer: pathogenesis of bone tropism and treatment strategy. | Q38581768 | ||
| Prostate cancer incidence and mortality in Portugal: trends, projections and regional differences | Q38835325 | ||
| Integrating pain metrics into oncology clinical trials | Q38948542 | ||
| Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials | Q38957147 | ||
| A systematic review of the impact of pain on overall survival in patients with cancer | Q39132056 | ||
| Management of Chronic Pain in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline | Q39169402 | ||
| How Do Hospital Palliative Care Teams Use the WHO Guidelines to Manage Unrelieved Cancer Pain? A 1-Year, Multicenter Audit in Japan | Q39182361 | ||
| Challenging the equipotency calculation for transdermal buprenorphine: four case studies | Q39325438 | ||
| Barriers to cancer pain relief: fear of tolerance and addiction. | Q39445566 | ||
| Treatment of cancer pain in Norway. A questionnaire study | Q39485550 | ||
| Cancer pain: progress since the WHO guidelines | Q40265384 | ||
| The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation | Q40382723 | ||
| Survival of male genital cancers (prostate, testis and penis) in Europe 1999-2007: Results from the EUROCARE-5 study | Q40483397 | ||
| Prevalence and management of pain in patients with metastatic cancer in Franche-Comté | Q40522532 | ||
| Cancer incidence predictions in the North of Portugal: keeping population-based cancer registration up to date | Q41443058 | ||
| Progress in the research on the mechanism of bone metastasis in lung cancer | Q41890747 | ||
| Bone Scan Index predicts skeletal-related events in patients with metastatic breast cancer | Q42416974 | ||
| Comments and Suggestions from Pain Specialists Regarding the CDC's Proposed Opioid Guidelines | Q43576588 | ||
| Sex Differences in Regional Brain Glucose Metabolism Following Opioid Withdrawal and Replacement | Q44344766 | ||
| Association of opioid requirement and cancer pain with survival in advanced non-small cell lung cancer | Q44347717 | ||
| Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial | Q44611376 | ||
| Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer | Q44634009 | ||
| Development of fever following first administration of zoledronate as a prognostic factor in advanced non-small cell lung cancer patients with bone metastases | Q47143899 | ||
| Defining pain: past, present, and future | Q47318794 | ||
| Relationship Between Using Clinical Practice Guidelines for Pain Treatment and Physicians' Training and Attitudes Toward Patients and the Effects on Patient Care. | Q47403956 | ||
| Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance). | Q47663622 | ||
| Efficacy and safety of 153Sm-EDTMP as treatment of painful bone metastasis: a large single-center study. | Q47684583 | ||
| Invasive techniques for pain management in palliative care: a single center experience | Q47940678 | ||
| Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey | Q48452749 | ||
| When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function | Q48821181 | ||
| Zoledronic Acid Dosing in Patients With Metastatic Breast Cancer | Q49384937 | ||
| Skeletal-related events and overall survival of patients with bone metastasis from nonsmall cell lung cancer - A retrospective analysis | Q49486387 | ||
| Updating the definition of pain | Q50136362 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | opioid | Q427523 |
| bone metastasis | Q848085 | ||
| brief pain inventory | Q4967024 | ||
| P304 | page(s) | 3362-3370 | |
| P577 | publication date | 2019-02-04 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | Pain prevalence and treatment in patients with metastatic bone disease | |
| P478 | volume | 17 |
| Q90727437 | Evaluating treatment modalities in chronic pain treatment by the multi-criteria decision making procedure | cites work | P2860 |
Search more.